Elanco Animal Health (ELAN +1.4%) has filed a Form CO with the European Commission related to its planned acquisition of Bayer AG’s (OTCPK:BAYRY +3.3%) animal health business. The routine submission is a standard part of the process for the regulatory nod on the deal.
Elanco announced the $7.6B tie-up in August 2019.
Source: Seeking Alpha